172 related articles for article (PubMed ID: 23557616)
1. Idiopathic pulmonary arterial hypertension in a young patient with the Cohen syndrome.
Cokkinos P; Gkouziouta A; Karavolias G; Kariofillis P; Voudris V
Hellenic J Cardiol; 2013; 54(2):143-6. PubMed ID: 23557616
[TBL] [Abstract][Full Text] [Related]
2. [Treatment with sildenafil, bosentan, or both in children and young people with idiopathic pulmonary arterial hypertension and Eisenmenger's syndrome].
Raposo-Sonnenfeld I; Otero-González I; Blanco-Aparicio M; Ferrer-Barba A; Medrano-López C
Rev Esp Cardiol; 2007 Apr; 60(4):366-72. PubMed ID: 17521545
[TBL] [Abstract][Full Text] [Related]
3. [Bosentan and chronic thromboembolic pulmonary hypertension].
Tomás C; Callejas-Rubio JL; Ríos-Fernández R; Ortego-Centeno N
Med Clin (Barc); 2007 Nov; 129(16):639. PubMed ID: 18001681
[No Abstract] [Full Text] [Related]
4. Pulmonary arterial hypertension: combination therapy in the modern management era.
Sitbon O
Eur Respir Rev; 2010 Dec; 19(118):348-9. PubMed ID: 21119195
[No Abstract] [Full Text] [Related]
5. Clinical practice: pulmonary hypertension in children.
De Wolf D
Eur J Pediatr; 2009 May; 168(5):515-22. PubMed ID: 19148677
[TBL] [Abstract][Full Text] [Related]
6. Bilateral angle closure glaucoma in a 28-year-old Cohen syndrome patient.
Li A; Gandhi A; Wang H; Traboulsi EI
Ophthalmic Genet; 2018 Oct; 39(5):657-658. PubMed ID: 29985682
[No Abstract] [Full Text] [Related]
7. Addition of sildenafil to bosentan monotherapy in pulmonary arterial hypertension.
Mathai SC; Girgis RE; Fisher MR; Champion HC; Housten-Harris T; Zaiman A; Hassoun PM
Eur Respir J; 2007 Mar; 29(3):469-75. PubMed ID: 17079256
[TBL] [Abstract][Full Text] [Related]
8. The management of Eisenmenger syndrome in the modern treatment era: a case report.
Gatzoulis MA
Eur Respir Rev; 2011 Dec; 20(122):293-6. PubMed ID: 22130823
[No Abstract] [Full Text] [Related]
9. [The treatment of idiopathic pulmonary artery hypertension and its relation to systemic scleroderma].
Humbert M
Rev Med Interne; 2007 Dec; 28 Suppl 4():S273-6. PubMed ID: 17961866
[No Abstract] [Full Text] [Related]
10. Bosentan for the treatment of portopulmonary hypertension.
Tempe DK; Datt V; Datta D
Ann Card Anaesth; 2008; 11(2):139-40; author reply 140. PubMed ID: 18603763
[No Abstract] [Full Text] [Related]
11. "Treat-to-target" in pulmonary arterial hypertension and the use of extracorporeal membrane oxygenation as a bridge to transplantation.
Hoeper MM
Eur Respir Rev; 2011 Dec; 20(122):297-300. PubMed ID: 22130824
[No Abstract] [Full Text] [Related]
12. Marked improvement with sildenafil in a patient with idiopathic pulmonary arterial hypertension unresponsive to beraprost and sarpogrelate.
Kawano H; Sengyoku H; Satoh O; Urabe S; Koide Y; Yano K
Intern Med; 2007; 46(12):893-8. PubMed ID: 17575385
[TBL] [Abstract][Full Text] [Related]
13. Consecutive use of sildenafil and bosentan for the treatment of pulmonary arterial hypertension associated with collagen vascular disease: sildenafil as reliever and bosentan as controller.
Kamata Y; Iwamoto M; Minota S
Lupus; 2007; 16(11):901-3. PubMed ID: 17971364
[TBL] [Abstract][Full Text] [Related]
14. Bosentan and sildenafil: should the combination therapy be a valid alternative in childhood to prostacyclin infusion?
Brancaccio G; Toscano A; Bevilacqua M; Di Chiara L; Parisi F
Pediatr Transplant; 2007 Feb; 11(1):110-2. PubMed ID: 17239133
[TBL] [Abstract][Full Text] [Related]
15. Combination drug therapy in the management of pulmonary arterial hypertension.
Kayser SR
Prog Cardiovasc Nurs; 2005; 20(4):177-82. PubMed ID: 16276142
[No Abstract] [Full Text] [Related]
16. Treatment of pulmonary hypertension in children with chronic lung disease with newer oral therapies.
Krishnan U; Krishnan S; Gewitz M
Pediatr Cardiol; 2008 Nov; 29(6):1082-6. PubMed ID: 18594787
[TBL] [Abstract][Full Text] [Related]
17. Combination therapy with sildenafil and bosentan reverts severe pulmonary hypertension and allows heart transplantation: case report.
Mogollón MV; Lage E; Cabezón S; Hinojosa R; Ballesteros S; Aranda A; Sobrino JM; Ordóñez A
Transplant Proc; 2006 Oct; 38(8):2522-3. PubMed ID: 17097987
[TBL] [Abstract][Full Text] [Related]
18. Therapy with sildenafil or bosentan decreases pulmonary vascular resistance in patients ineligible for heart transplantation because of severe pulmonary hypertension.
Perez-Villa F; Farrero M; Sionis A; Castel A; Roig E
J Heart Lung Transplant; 2010 Jul; 29(7):817-8. PubMed ID: 20363156
[No Abstract] [Full Text] [Related]
19. Better off blue: BMPR-2 mutation, arteriovenous malformation, and pulmonary arterial hypertension.
Soon E; Southwood M; Sheares K; Pepke-Zaba J; Morrell NW
Am J Respir Crit Care Med; 2014 Jun; 189(11):1435-6. PubMed ID: 24881940
[No Abstract] [Full Text] [Related]
20. Directing therapy in pulmonary arterial hypertension using a target 6 min walk distance.
Porhownik NR; Myers R; Bshouty Z
Can Respir J; 2013; 20(2):111-5. PubMed ID: 23616968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
